Latest News and Press Releases
Want to stay updated on the latest news?
-
Azalea reports new preclinical data showing efficient in vivo TRAC-CAR T generation, tumor clearance in mice and first-in-primate on-target activity.
-
Azalea Therapeutics launches with $82M to advance precision in vivo genome engineering, creating therapeutic cells directly inside patients.